US equities
|
MU
$910.50
▲+0.62%
NVDA
$217.55
▲+0.21%
TSLA
$373.87
▲+1.58%
META
$691.74
▼-1.94%
SPCX
$147.33
▼-0.43%
SNDK
$1,375.89
▲+0.35%
AMZN
$263.47
▲+0.39%
AMD
$542.39
▲+0.81%
MU
$910.50
▲+0.62%
NVDA
$217.55
▲+0.21%
TSLA
$373.87
▲+1.58%
META
$691.74
▼-1.94%
SPCX
$147.33
▼-0.43%
SNDK
$1,375.89
▲+0.35%
AMZN
$263.47
▲+0.39%
AMD
$542.39
▲+0.81%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about XCNQ:MBIO
Recent news which mentions XCNQ:MBIO
Mindbio Announces Intention To Refile MD & A
February 14, 2025
Tickers
MBIO
Tags
#Mining
MindBio Therapeutics
#Psychedelics
From
TheNewswire.com - RSS (Media)
Mindbio Announces Clinical Trial Milestone In Phase 2B Microdosing Trials Targeting Existential Distress, Depression & Anxiety In Advanced Stage Cancer
October 24, 2024
Tickers
MBIO
Tags
#Healthcare
XCNQ:MBIO
#Medical
From
TheNewswire.com - RSS (Media)